Landmark medicines deal to boost nation’s health, save NHS £14 billion, and support research investment

ABPI

20 November 2023 - Pro-innovation and pro-competition agreement will introduce a new mechanism to support lower industry payment rates for more innovative and pioneering branded medicines.

A landmark deal has been agreed that is set to save the NHS £14 billion over five years in medicines costs, enable patients to access the latest lifesaving treatments more consistently, and boost the UK’s position as a global superpower in advanced healthcare, technology, and clinical research.

Read ABPI press release 

Michael Wonder

Posted by:

Michael Wonder